Back to search results

HER2 Chimeric Antigen Receptor (CAR) T Cells in Combination With Checkpoint Blockade in Patients With Advanced Sarcoma

Abroad (travel likely)RecruitingPHASE1

Conditions

Sarcoma · HER-2 Protein Overexpression · Osteosarcoma · Rhabdomyosarcoma · Ewing Sarcoma · Synovial Sarcoma · Soft Tissue Sarcoma · Undifferentiated Sarcoma

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

  • Texas Children's Hospital, Houston, Texas, United States

Study leads

  • Meenakshi Hegde, MD

    Principal Investigator

    Baylor College of Medicine

  • Shoba Navai, MD

    Principal Investigator

    Baylor College of Medicine

  • Nabil Ahmed, MD

    Principal Investigator

    Baylor College of Medicine

View source on ClinicalTrials.gov(opens in a new tab)